The prostaglandin D(2) receptor 2 pathway in asthma: a key player in airway inflammation

por Domingo, Christian, Palomares, Oscar, Sandham, David A., Erpenbeck, Veit J., Altman, Pablo
Publicado 2018

Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers

por Thum, Thomas, Erpenbeck, Veit J., Moeller, Julia, Hohlfeld, Jens M., Krug, Norbert, Borlak, Jürgen
Publicado 2006

Prostaglandin D(2) metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP(2) receptor

por Carstensen, Saskia, Gress, Christina, Erpenbeck, Veit J., Kazani, Shamsah D., Hohlfeld, Jens M., Sandham, David A., Müller, Meike
Publicado 2021

Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein D

por Schleh, Carsten, Erpenbeck , Veit J, Winkler, Carla, Lauenstein, Hans D, Nassimi, Matthias, Braun, Armin, Krug, Norbert, Hohlfeld, Jens M
Publicado 2010

Cell Counting in Human Endobronchial Biopsies - Disagreement of 2D versus 3D Morphometry

por Bratu, Vlad A., Erpenbeck, Veit J., Fehrenbach, Antonia, Rausch, Tanja, Rittinghausen, Susanne, Krug, Norbert, Hohlfeld, Jens M., Fehrenbach, Heinz
Publicado 2014

The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure

por Schleh, Carsten, Mühlfeld, Christian, Pulskamp, Karin, Schmiedl, Andreas, Nassimi, Matthias, Lauenstein, Hans D, Braun, Armin, Krug, Norbert, Erpenbeck, Veit J, Hohlfeld, Jens M
Publicado 2009

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

por Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Publicado 2016

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Vol...

por Erpenbeck, Veit J., Vets, Eva, Gheyle, Lien, Osuntokun, Wande, Larbig, Michael, Neelakantham, Srikanth, Sandham, David, Dubois, Gerald, Elbast, Walid, Goldsmith, Paul, Weiss, Markus
Publicado 2016

Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD

por Winkler, Carla, Atochina-Vasserman, Elena N, Holz, Olaf, Beers, Michael F, Erpenbeck, Veit J, Krug, Norbert, Roepcke, Stefan, Lauer, Gereon, Elmlinger, Martin, Hohlfeld, Jens M
Publicado 2011

Surfactant Protein D modulates allergen particle uptake and inflammatory response in a human epithelial airway model

por Schleh, Carsten, Rothen-Rutishauser, Barbara M, Blank, Fabian, Lauenstein, Hans D, Nassimi, Matthias, Krug, Norbert, Braun, Armin, Erpenbeck, Veit J, Gehr, Peter, Hohlfeld, Jens M
Publicado 2012

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

por Metz, Martin, Staubach, Petra, Bauer, Andrea, Brehler, Randolf, Gericke, Janine, Kangas, Michael, Ashton-Chess, Joanna, Jarvis, Philip, Georgiou, Panayiotis, Canvin, Janice, Hillenbrand, Rainer, Erpenbeck, Veit J., Maurer, Marcus
Publicado 2017

The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D(2) Production Are Attenuated by PGD(2) Receptor 2 Antagonism

por Chen, Wentao, Luo, Jian, Ye, Yuan, Hoyle, Ryan, Liu, Wei, Borst, Rowie, Kazani, Shamsah, Shikatani, Eric A., Erpenbeck, Veit J., Pavord, Ian D., Klenerman, Paul, Sandham, David A., Xue, Luzheng
Publicado 2021